Infective endocarditis

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

最后审阅: 17 Feb 2026
最后更新: 23 Apr 2025

小结

定义

病史和体格检查

关键诊断因素

  • presence of risk factors
  • definite IE per diagnostic criteria
  • fever/chills
  • cardiac murmur
  • night sweats, malaise, fatigue, anorexia, weight loss, myalgias
  • weakness
  • arthralgias
  • headache
  • shortness of breath
  • meningeal signs
  • Janeway lesions
  • Osler nodes
  • Roth spots
完整详情

其他诊断因素

  • splinter haemorrhages
  • cutaneous infarcts
  • chest pain
  • back pain
  • palatal petechiae
完整详情

危险因素

  • prior history of infectious endocarditis
  • presence of artificial prosthetic heart valves
  • certain types of congenital heart disease
  • post-organ transplant (patients who develop a cardiac valvulopathy)
  • presence of cardiac implanted electronic device or intravascular catheters (e.g., for haemodialysis)
  • acquired degenerative valve disease
  • mitral valve prolapse (MVP) with valvular regurgitation
  • hypertrophic cardiomyopathy
  • intravenous drug use
  • chronic Q fever
完整详情

诊断性检查

首要检查

  • blood cultures
  • echocardiography
  • full blood count
  • CRP
  • serum urea, electrolytes, and glucose
  • liver function tests
  • urinalysis
  • ECG
完整详情

需考虑的检查

  • rheumatoid factor/other immunological blood tests
  • erythrocyte sedimentation rate
  • complement levels
  • computed tomography
  • magnetic resonance imaging
  • nuclear imaging and photon emission tomography (PET)
完整详情

新兴检查

  • troponin I
完整详情

治疗流程

初步治疗

suspected infective endocarditis

急症处理

native valve: confirmed infective endocarditis

prosthetic valve: confirmed infective endocarditis

持续性治疗

at high risk of infective endocarditis

撰稿人

专家顾问

Mamta Buch, MBChB, PhD, FRCP

Consultant Interventional Cardiologist

Manchester University NHS Foundation Trust

Manchester

UK

利益声明

MHB has received speaker honoraria relating to transcatheter heart valve intervention: Medtronic, Edwards. Advisory board relating to transcatheter heart valve intervention: Abbott. MHB is Education Secretary for the British Heart Valve Society and member of the British Cardiovascular Intervention Society Structural Heart working group. MHB has faculty roles at national and international structural heart intervention meetings.

鸣谢

BMJ Best Practice would like to gratefully acknowledge the previous expert contributors, whose work has been retained in parts of the content:

Tracey Keteepe-Arachi BSc (Hons), MBBS, MRCP (UK)

Cardiology Specialist Registrar and Clinical Research Fellow

Department of Cardiovascular Sciences

St George's Hospital Medical School

University of London

London

UK

Disclosures: TKA declares that she has no competing interests.

Aneil Malhotra MA (Hons), MSc, MB BChir, MRCP (UK)

Cardiology Specialist Registrar and Clinical Research Fellow

Department of Cardiovascular Sciences

St George's Hospital Medical School

University of London

London

UK

Disclosures: AM is an author of a number of references cited in this topic.

Michael Papadakis MD, MRCP (UK)

Clinical Lecturer in Cardiology

St George's University of London

London

UK

Disclosures: MP declares that he has no competing interests.

同行评议者

Bernard Prendergast, BMedSci, BM, BS, MD, FRCP, FESC

Professor of Interventional Cardiology and Valvular Heart Disease

St Thomas' Hospital

London

UK

利益声明

BP declares that he has no competing interests.

Brian Angus, BSc MBChB, MD, FRCP

Professor

Oxford University

The John Radcliffe

Oxford

UK

利益声明

BA declares he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042.全文  摘要

National Institute for Health and Care Excellence. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. July 2016 [internet publication].全文

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности